Ge Long Hui A P P·2026-01-13 06:47Group 1 - The core viewpoint of the article highlights that Xianle Health is a leading CDMO enterprise in the health supplement sector, focusing on the research and manufacturing of health and functional foods [1] - The company has demonstrated a stable performance with a projected CAGR of 18% for both revenue and net profit attributable to the parent company from 2012 to 2024, leading the industry [1] - Xianle Health possesses multiple R&D centers and has superior innovation and insight capabilities, allowing it to quickly capture market trends and efficiently bring products to market [1] Group 2 - The company has a comprehensive production line and a flexible supply system, enabling rapid product launch and feedback to key clients [1] - It is innovating with new dosage forms (such as burst beads and Xueyou yogurt®) and expanding into six high-potential categories, including anti-aging, probiotics, beauty and health, cardiovascular metabolism, immune enhancement, and sports nutrition [1] - Given the significant overseas market potential and the company's competitive advantages in R&D and supply chain, the current valuation is considered cost-effective, maintaining a "buy" rating [1]